These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37852432)

  • 1. De novo biosynthesis of anticarcinogenic icariin in engineered yeast.
    An T; Lin G; Liu Y; Qin L; Xu Y; Feng X; Li C
    Metab Eng; 2023 Nov; 80():207-215. PubMed ID: 37852432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Developing a Yeast Cell Factory for the Production of Prenylated Flavonoids.
    Levisson M; Araya-Cloutier C; de Bruijn WJC; van der Heide M; Salvador López JM; Daran JM; Vincken JP; Beekwilder J
    J Agric Food Chem; 2019 Dec; 67(49):13478-13486. PubMed ID: 31016981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo biosynthesis of sakuranetin from glucose by engineered Saccharomyces cerevisiae.
    Tu S; Xiao F; Mei C; Li S; Qiao P; Huang Z; He Y; Gong Z; Zhong W
    Appl Microbiol Biotechnol; 2023 Jun; 107(12):3899-3909. PubMed ID: 37148336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo production of the flavonoid naringenin in engineered Saccharomyces cerevisiae.
    Koopman F; Beekwilder J; Crimi B; van Houwelingen A; Hall RD; Bosch D; van Maris AJ; Pronk JT; Daran JM
    Microb Cell Fact; 2012 Dec; 11():155. PubMed ID: 23216753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo biosynthesis of the hops bioactive flavonoid xanthohumol in yeast.
    Yang S; Chen R; Cao X; Wang G; Zhou YJ
    Nat Commun; 2024 Jan; 15(1):253. PubMed ID: 38177132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Engineering of
    Xiao F; Lian J; Tu S; Xie L; Li J; Zhang F; Linhardt RJ; Huang H; Zhong W
    ACS Synth Biol; 2022 Feb; 11(2):800-811. PubMed ID: 35107250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering Saccharomyces cerevisiae with the deletion of endogenous glucosidases for the production of flavonoid glucosides.
    Wang H; Yang Y; Lin L; Zhou W; Liu M; Cheng K; Wang W
    Microb Cell Fact; 2016 Aug; 15(1):134. PubMed ID: 27491546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous biosynthesis and manipulation of crocetin in Saccharomyces cerevisiae.
    Chai F; Wang Y; Mei X; Yao M; Chen Y; Liu H; Xiao W; Yuan Y
    Microb Cell Fact; 2017 Mar; 16(1):54. PubMed ID: 28356104
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li H; Zhang S; Dong Z; Shan X; Zhou J; Zeng W
    J Agric Food Chem; 2024 Sep; 72(35):19436-19446. PubMed ID: 39180741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic engineering of Saccharomyces cerevisiae for high-level production of (+)-ambrein from glucose.
    Lin C; Zhang X; Ji Z; Fan B; Chen Y; Wu Y; Gan Y; Li Z; Shang Y; Duan L; Wang F
    Biotechnol Lett; 2024 Aug; 46(4):615-626. PubMed ID: 38884886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic engineering of Saccharomyces cerevisiae for high-level production of gastrodin from glucose.
    Yin H; Hu T; Zhuang Y; Liu T
    Microb Cell Fact; 2020 Nov; 19(1):218. PubMed ID: 33243241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Engineering of Saccharomyces cerevisiae for De Novo Production of Kaempferol.
    Lyu X; Zhao G; Ng KR; Mark R; Chen WN
    J Agric Food Chem; 2019 May; 67(19):5596-5606. PubMed ID: 30957490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo resveratrol production through modular engineering of an Escherichia coli-Saccharomyces cerevisiae co-culture.
    Yuan SF; Yi X; Johnston TG; Alper HS
    Microb Cell Fact; 2020 Jul; 19(1):143. PubMed ID: 32664999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis and engineering of kaempferol in Saccharomyces cerevisiae.
    Duan L; Ding W; Liu X; Cheng X; Cai J; Hua E; Jiang H
    Microb Cell Fact; 2017 Sep; 16(1):165. PubMed ID: 28950867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering
    Du Y; Yang B; Yi Z; Hu L; Li M
    J Agric Food Chem; 2020 Feb; 68(7):2146-2154. PubMed ID: 31984739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo biosynthesis of bioactive isoflavonoids by engineered yeast cell factories.
    Liu Q; Liu Y; Li G; Savolainen O; Chen Y; Nielsen J
    Nat Commun; 2021 Oct; 12(1):6085. PubMed ID: 34667183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of Pinocembrin Biosynthesis in
    Tous Mohedano M; Mao J; Chen Y
    ACS Synth Biol; 2023 Jan; 12(1):144-152. PubMed ID: 36534476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered yeast for efficient de novo synthesis of 7-dehydrocholesterol.
    Qu L; Xiu X; Sun G; Zhang C; Yang H; Liu Y; Li J; Du G; Lv X; Liu L
    Biotechnol Bioeng; 2022 May; 119(5):1278-1289. PubMed ID: 35128633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic engineering of yeast for fermentative production of flavonoids.
    Rodriguez A; Strucko T; Stahlhut SG; Kristensen M; Svenssen DK; Forster J; Nielsen J; Borodina I
    Bioresour Technol; 2017 Dec; 245(Pt B):1645-1654. PubMed ID: 28634125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing yeast for high-level production of kaempferol and quercetin.
    Tartik M; Liu J; Mohedano MT; Mao J; Chen Y
    Microb Cell Fact; 2023 Apr; 22(1):74. PubMed ID: 37076829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.